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Abstract 
 
Chronic tendon pathology is a common, and often disabling condition, the causes of 
which remain poorly understood. The continuum model of tendon pathology was 
proposed in order to provide a model for the staging of tendon pathology, and to assist 
clinicians in managing this often complex condition (Cook and Purdam 2009). The 
model presents clinical, histological and imaging evidence for the progression of 
tendon pathology as a three-stage continuum: reactive tendinopathy, tendon disrepair, 
and degenerative tendinopathy. It also provides clinical information to assist in 
identifying the stage of pathology, in addition to proposed treatment approaches for 
each stage. The usefulness of such a model is determined by its ability to incorporate 
and inform new and emerging research. This review examines the degree to which 
recent research supports or refutes the continuum model, and proposes future 
directions for clinical and research application of the model.  
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Introduction 
Chronic tendon pathology, or tendinopathy, is a highly prevalent musculoskeletal 
condition affecting both athletes and non-athletes, with the most commonly affected 
tendons being the Achilles, patella, rotator cuff and elbow extensor tendons. Clinical 
management of tendinopathy can be challenging, and clinical trials have failed to 
provide robust evidence for many of the commonly used interventions (Krogh et al 
2012, Coombes et al 2010, Woodley et al 2007). However, since it is broadly agreed 
that there is much yet to be understood about the causes of tendinopathy (Riley 2008), 
it is perhaps unsurprising that clinical trials including patients with a range of degrees 
of tendinopathy report equivocal results (Bennell et al 2010).  
 
This review focuses on the continuum model of tendon pathology, as proposed by 
Cook and Purdam (2009), which provides a model for the staging of tendon 
pathology. Historically, research, assessment and treatment of tendon pathology were 
focused around an inflammatory model of pathology, which progressed to a 
perspective of the pathology as “failed healing”, followed by the more recent view of 
a primarily degenerative pathology with minimal inflammatory influence (Mafulli et 
al 1998). A number of authors have provided theoretical models to explain the basis 
for development of tendon pathology, or to assist clinicians in managing this 
condition. Neer (1972) and Blazina (1973) proposed what are essentially classification 
systems for the rotator cuff and patellar tendon respectively. Nirschl (1992) went a 
step further, and proposed a 5-stage model to describe the progression of tendon 
pathology using tennis elbow as an example. This model integrated pathological, 
histological and clinical findings and described a range of tendon states from healthy, 
through acute and chronic tendonitis, to tendinosis and rupture. Coombes et al (2009) 
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advanced the modelling of lateral epicondylalgia with a framework that incorporated 
local changes in the muscle and tendon, along with changes in the wider pain system. 
The EdUReP model was developed by Davenport et al (2005) and is a theoretical 
framework for the conservative management of tendinopathy, with emphasis on the 
importance of patient education and controlled loading. However this model did not 
consider the staging of tendon pathology, or incorporate the growing area of tendon 
imaging.  
 
In response to the need for a model which would provide an explanation for the 
diverse presentations of tendinopathy, while also providing a useful tool for clinicians, 
Cook and Purdam (2009) proposed a generic model of tendon pathology based around 
a continuum model, incorporating clinical, histological and imaging information. The 
model describes the early stages of reactive tendon pathology as a non-inflammatory 
proliferative tissue reaction, usually in response to acute overload or compression. 
The tendon thickens due to the up-regulation of large proteoglycans, and an increase 
in bound water, with minimal collagen damage or separation. Tendon disrepair is 
characterised by greater tissue matrix breakdown, with collagen separation, 
proliferation of abnormal tenocytes, and some increase in tendon neovascularity. 
These two stages are considered to have some degree of reversibility, with the 
appropriate healing environment. The final stage of degenerative tendinopathy sees a 
further disruption of collagen, widespread cell death, and extensive ingrowth of 
neovessels and nerves into the tendon substance, leading to an essentially irreversible 
stage of pathology. The model is highly clinically applicable, with a framework 
describing how treatments might be best aligned with the stage of tendinopathy, along 
with descriptions of the clinical presentation of each stage. This model has the 
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potential to provide a basis for more targeted assessment and treatment approaches in 
tendinopathy, however it was primarily based on lower limb tendinopathy. Lewis 
(2010) subsequently applied the model to rotator cuff tendinopathy, incorporating 
bursal pathology, and further emphasising the importance of optimal loading in 
maintaining normal tendon function and health. Cook and Purdam (2009) stated that 
the usefulness of this new continuum model will be evidenced in how successfully it 
can incorporate new and emerging research from pathology, clinical and imaging 
perspectives. Its applicability to practice will be proven by its uptake by clinicians for 
the assessment and management of tendinopathy. This review aims to evaluate the 
degree to explore recent tendon research in the context of the continuum model, and 
propose future directions for clinical and research application of the model.  
 
Pathology studies 
 
Recent studies of rotator cuff tendinopathy have provided further histochemical 
evidence for the idea of tendinopathy as a continuum. Longo et al (2011) showed that 
smaller tears had more cell proliferation, and greater inflammatory cell infiltrate than 
larger tears, where collagen degeneration was predominant, and few cells were 
present. Similarly, Murphy et al (2012) examined tissue biopsy specimens from 45 
patients with varying degrees of imaging or arthroscopically diagnosed rotator cuff 
pathology.  There was significant reduction in vascularity and cell proliferation as 
pathology progressed towards the most degenerative stage. The results provide 
evidence of an early inflammatory component in those with tendinopathy but no 
tendon tears i.e. reactive or early disrepair stage, while in the later degenerative stages 
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of pathology (patients requiring arthroscopic surgery) there is reduced proliferative 
and vascular activity within the pathological  tendon tissue.  
 
A comprehensive review of the pathophysiology of tendinopathy was provided by 
Abate et al (2009) describing a “pathogenetic cascade” in which inflammation and 
degeneration are often concurrent processes. They describe how inflammatory, 
regenerative and degenerative changes proceed in parallel across early to late stage 
tendinopathies, resulting in a continuum ranging from healthy tendon to overt painful 
tendinopathy.  Using an “iceberg model”, they propose that asymptomatic 
tendinopathy converts to symptomatic when higher levels of neural and vascular 
proliferative change have occurred. Determining the source of pain in tendinopathy 
remains a significant challenge for researchers. Current theories suggest that the pain 
arises from biochemical irritants (Fredberg and Stengaard-Pederson 2008), peri-
tendinous tissues (Van Sterkenburg and Niek van Dijk 2011), or neurovascular 
ingrowth (Lian et al 2006). However, none of these factors have yet been correlated 
with a subjective measure of pain, and for example, neovascularisation has been 
widely shown to have little correlation with symptoms or clinical outcome despite the 
widespread use of injection therapies aimed at reducing it (Wilde et al 2011, Tol et al 
2012). Therefore, while the pathological basis for the continuum model remains well 
supported, the process of transition towards pain in the structurally abnormal tendon is 
yet to be elucidated.  
 
Healthy tendons are ‘plastic’ structures, capable of adapting to the load environment 
through alterations of their structural and mechanical properties (Killian et al 2012). 
The continuum model is strongly based around the effects of loading or unloading on 
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tendon. The response of tendon to loading has been evaluated experimentally in a 
variety of animal models (Edelstein et al 2011). While the application of this research 
has been perhaps primarily targeted towards developing surgical techniques for 
tendon tears, there is wide potential for such research to inform both the pathological 
basis for, and clinical application of the continuum model. For example, studies of 
fatigue loading in rats have demonstrated distinctly different tendon responses to 
different levels of strain. Sun et al (2008) demonstrated a dose-response effect in rat 
patellar tendon in vivo when undergoing cyclic loading, where lower strain levels 
produced a more favourable tissue deformation pattern than moderate or high strain, 
along with suppression of the activity of pro-inflammatory mediators, versus an 
increase in these substances in the tendons loaded to higher fatigue levels. Such an in 
vivo model offers potential to provide further histo-pathological and biochemical 
evidence to support choosing different exercise interventions for various stages of 
tendinopathy in humans.   
 
In additional to exposure to loading, there are a multitude of extrinsic and intrinsic 
factors that may influence the development of tendinopathy (Lewis 2010). Extrinsic 
factors include local anatomical factors, posture and biomechanical factors, and 
occupational and sporting activities. Intrinsic and personal factors are also important 
in the pre-disposition of certain individuals to tendinopathy.  Genetic factors have 
been identified as a predisposing factor in rotator cuff (Chaudhry and Carr 2012) and 
Achilles tendinopathy (Legerlotz et al 2012, Posthumus et al 2010). Metabolic factors 
also play a role in tendinopathy, with diabetes being a well known risk factor (de 
Oliveira et al 2011), and associations between adiposity and tendinopathy noted in 
both Achilles (Gaida et al 2009) and gluteal tendinopathy (Fearon et al 2012). Other 
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than age, none of the tendinopathy models have incorporated intrinsic factors, perhaps 
due to their limited modifiability. However, such factors may be important in 
prognosis setting, with poorer capacity for recovery in affected individuals. 
 
Knowledge about pain physiology in relation to musculoskeletal pathologies has 
advanced greatly in recent years, with a strong emphasis now being placed on the 
consideration of central sensitisation mechanisms, as well as psychosocial factors, in 
spinal pain in particular (Moseley et al 2003). There has been limited investigation of 
the role of these mechanisms in the development of chronic tendon pain. Studies of 
common elbow extensor tendinopathy have demonstrated the presence of mechanical 
hyperalgesia, both locally at the tendon site and contralaterally, which has been 
proposed to be an indicator of sensitisation of the central nervous system (Coombes et 
al 2009). Similarly, lowered mechanical pain thresholds have been demonstrated in 
patellar and shoulder tendinopathy (van Wilgen et al 2011, Hidalgo-Lozano et al 
2010). Studies of risk factors for rotator cuff dysfunction in occupational populations 
have generally emphasised the role of mechanical and work-related factors in the 
development of the disorder (van Rijn et al 2010), however psychosocial factors may 
be important in prognosis and development of chronicity (Horsley 2011). While this is 
an area that requires further research, with findings that may differ according to the 
site of tendinopathy and population, it appears important that the relative contribution 
of local versus central dysfunction to the individual’s pain presentation is considered 
in order to provide the most appropriate treatment.  
 
Therefore, the continuum model continues to be supported by pathological research, 
with the possibility for animal studies to further reinforce the recommendations for 
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load progression in tendinopathy rehabilitation. Ongoing developments in the 
understanding of how genetic, and metabolic factors, as well as pain physiology, may 
affect tendinopathy may be important to incorporate as the continuum model evolves.  
 
Clinical studies 
 
It is difficult to apply the continuum model to clinical studies, as no published clinical 
studies have attempted to subgroup or analyse tendinopathy participants according to 
stage or degree of pathology. In fact most studies include a heterogenous population 
of people with pathology of varying duration and severity. However, in an attempt to 
apply the continuum approach to existing studies, two studies of rotator cuff 
tendinopathy with conflicting results will be discussed. Holmgren et al (2012) carried 
out a randomised clinical trial involving rotator cuff tendinopathy patients who were 
on a waiting list for subacromial decompression. It is probable that this group of 
patients were from a relatively homogenous population that may have corresponded 
with the disrepair or degenerative sub-categories. The trial compared specific loading 
exercises, including an eccentric component, to a simple range of motion exercise 
programme (control). The specific exercise group had significantly better 
improvement in their functional scores at 12 week follow-up, and only 20% of this 
group went on to have surgery, versus 63% of the control group. In a study with 
contrasting results, Bennell et al (2010) recruited people with shoulder pain from 
primary care and community settings, and randomised them to receive an exercise and 
manual therapy intervention or a placebo ultrasound treatment. At the 11 week 
follow-up, there was no difference between groups in pain and disability scores, and, 
although the active exercise group showed better improvement in functional scores at 
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22 weeks, there was no significant between-group difference in pain at this time point. 
It is likely that the recruitment strategy used by Bennell et al (2010) resulted in quite a 
heterogenous group of participants, across the spectrum of rotator cuff tendon 
pathology. Since the continuum model suggests that reactive tendinopathy may 
benefit from reduced loading, it is possible that participants within the reactive 
subcategory would have done better in the placebo group, as ultrasound is a form of 
passive unloading, and active exercise may have exacerbated any reactivity present. 
The only directly comparable outcome measure at baseline between the two studies 
was the Visual Analogue Scale for pain. Mean resting pain was similar in the two 
studies (1.7 in the Holmgren study and  2.2 in the Bennell et al study), however 
activity related pain was higher in the Holmgren et al study ( 6.4 compared to 4.9 in 
the Bennell et al study), possibly supporting the greater degree of tendon pathology in 
the Holmgren study. As these studies were not designed in line with the continuum 
model, this discussion remains speculative. To further investigate this, future research 
investigations in tendinopathy could be designed to assess outcome against targeted 
interventions, according to the sub-categories of the continuum model.  
 
Corticosteroid (CS) injection has been shown to be successful in treating pain in the 
short-term in both patellar and rotator cuff tendinopathy, however this benefit 
diminishes in the long-term or with more chronic presentations (Smidt et al 2002, 
Kongsgaard et al 2009). Van Ark et al (2011), in a recent systematic review of 
injections for patellar tendinopathy, suggest that different injections may be suitable 
for different stages of disease. For example, for reactive or early stage pathology, 
corticosteroid may be suitable to address the inflammatory and proliferative 
mechanisms involved while for disrepair/degenerative stage other types of injection 
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such as platelet-rich plasma, may be more suitable, in conjunction with loading 
programme, as they have a more regenerative mechanism of effect. Matthews et al 
(2006), in a histological study of rotator cuff tears, suggest that the use of CS injection 
for small rotator cuff tears may in fact be detrimental, reducing their ability to heal 
and directing the tissue into a more degenerative, metabolically inert state. Injections 
provide another example of a treatment which could be optimised by targeting to the 
appropriate stage of tendon pathology.  
 
Imaging studies 
 
There have been a number of imaging based studies involving athletic populations 
that have provided evidence for the continuum model. Malliaris et al (2011) examined 
the patellar tendons of 58 volleyball players on a monthly basis using ultrasound 
imaging, and demonstrated that tendons transitioned between different stages of 
pathology e.g. normal to diffuse thickening, or hypoechoic to diffuse thickening. 
There was also a significant association between greyscale ultrasound changes and the 
presence of pain, with pain most likely if the tendon contained a hypoechoic region.  
Fredberg and Bolvig (2002) studied previously asymptomatic football players found 
that only players with sonographically abnormal patellar tendons at the beginning of 
the season went on to develop painful tendons, with no occurrence of pain in players 
who were sonographically normal in the pre-season.  In a recent longitudinal study of 
aysmptomatic ballet dancers, the presence of moderate or severe hypoechoic defects 
in the patellar and Achilles tendons on ultrasound was a weak predictor of the 
development of tendon-related pain and disability (Comin et al 2012).  
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In contrast, imaging has not provided a good basis for determining the outcome of 
treatment for tendinopathy. Ekeberg et al (2010) described a prognostic study 
examining factors associated with the success of corticosteroid injections in RC 
disease, and found that imaging findings (MRI and US) were not good predictors of 
patient outcome. Drew et al (2012) systematically reviewed the evidence for the 
relationship between structural changes in tendon and the outcome of treatment, and 
made a strong argument against the use of structural changes to explain the effect of 
therapeutic interventions for tendinopathy. However, they suggest that imaging could 
perhaps be used to identify diagnostic sub-types within tendinopathy populations in 
order to better target treatment.  
 
One of the biggest challenges in terms of the use of imaging in tendinopathy is the 
high degree of prevalence of asymptomatic structural changes -it is not possible as yet 
to differentiate between symptomatic and asymptomatic tendon pathology on any 
form of imaging (Moosmayer et al 2009). Similar issues in diagnostic radiology for 
spinal and knee pain have caused some authors to call for more judicious use of 
imaging in the clinical setting, and a need for better integration with clinical findings 
(Chou 2009, Englund et al 2008). Ultrasound has traditionally been the preserve of 
radiologists, but in recent years has been increasingly adopted as a “point of care” 
imaging modality by rheumatologists, sports medicine physicians and 
physiotherapists (Yim and Corrado 2012). This development could be a positive step 
towards better integration of imaging findings as part of the full clinical examination, 
which aligns well within the framework presented in the continuum model. 
Tendinopathy is often associated with ‘latent’ symptoms, developing subsequent to 
aggravating activity. The development of imaging protocols to assess changes in 
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tendon properties (e.g. vascularity, thickness) in response to loading i.e. immediately 
after, 24 hours after) may be another method which could help identify tendons in the 
reactive stage of pathology (Shalabi et al 2004).  
 
Newer protocols have opened up the possibilities for ultrasound imaging to contribute 
to knowledge regarding the structural properties of tendons. Ultrasound tissue 
characterisation (UTC) is a method which quantifies echo patterns in the greyscale US 
image, and provides a 3D reconstruction, which has been shown to be related to 
tendon histopathology (Van Schie et al 2003). A small study in chronic Achilles 
tendinopathy found that UTC could reliably distinguish between symptomatic and 
asymptomatic tendons (van Schie et al 2010). Arya and Kulig (2010) used dynamic 
ultrasound imaging and dynamometry to assess the stiffness, stress and strain of the 
Achilles tendon during isometric activity in men with Achilles tendinopathy and 
matched controls. Tendinopathic tendons exhibited a loss of stiffness and a reduced 
Young’s modulus (stiffness normalised to tendon geometry), potentially related to the 
loss of collagen structure in the pathological tendons, and giving some explanation for 
the loss of functional performance. Similar imaging methods were used by Morrissey 
et al (2011) to demonstrate a greater increase in Achilles tendon stiffness in response 
to an eccentric exercise programme in healthy individuals, compared to a similar 
group undergoing a concentric programme. Notwithstanding the potential limitations 
of this 2D method in assessing what is a 3D phenomenon (Magnusson et al 2008), it 
offers at least some increased capacity to model tendon properties dynamically in-
vivo, and in response to therapeutic interventions. Sonoelastography is another 
ultrasound-based method which provides an estimation of tissue elasticity or 
‘hardness’, with pathological areas of tendon exhibiting a softer tissue spectrum. De 
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Zordo et al (2009) showed that sonoelastography is highly sensitive and specific in 
identifying regions of pathology in the common extensor tendons of patients with 
clinical signs of lateral epicondylar pain. Further refinement of this technique is likely 
to provide useful information in staging and treatment planning in tendinopathy 
(Klauser et al 2010). 
 
Scott and Khan (2010) discuss how a preventive treatment model for tendinopathy 
using imaging may be a way forward; where susceptible patients could be identified 
early on using ultrasound imaging, and suitable rehabilitative measures instigated. 
Fredberg et al (2008) undertook a preventive study aimed at preventing the onset of 
patellar tendinopathy in soccer players, where players with sonographically abnormal 
tendons undertook a prophylactic strengthening and stretching programme. This 
programme failed to prevent development of symptoms, and may in fact have 
increased the risk in some players. As such, the content of any preventive or early 
stage programme remains to be determined; however an effective programme could 
have widespread benefit in reducing the personal and economic cost of chronic 
tendinopathies. 
 
Summary 
 
It is clear that the continuum model continues to be supported by pathological 
research, however clinical research has continued to favour a heterogeneous model of 
tendon pathology, with the result that the optimal intervention for each stage of 
pathology is still unknown. While imaging has failed to provide a mechanism for this 
staging process to date, suggestions have been made as to how new developments in 
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imaging technology may be able to further develop this process. The continuum 
model could be supplemented with prognostic information in terms of patient –based 
factors, both physical and psychosocial, in order to optimise its use in terms of 
treatment choice for the individual patient.  
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